<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>Multi-Modality Optimal Radiation Treatments</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>05/01/2016</AwardEffectiveDate>
<AwardExpirationDate>04/30/2020</AwardExpirationDate>
<AwardTotalIntnAmount>299919.00</AwardTotalIntnAmount>
<AwardAmount>299919</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07030000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>CMMI</Abbreviation>
<LongName>Div Of Civil, Mechanical, &amp; Manufact Inn</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Georgia-Ann Klutke</SignBlockName>
<PO_EMAI>gaklutke@nsf.gov</PO_EMAI>
<PO_PHON>7032922443</PO_PHON>
</ProgramOfficer>
<AbstractNarration>Cancer is one of the leading causes of death in the United States, affecting many families.  Various radiation treatment modalities, such as photons, protons, and neutrons, are currently used in an effort to eradicate cancer cells while preserving the functionality of healthy tissue. Each modality has its own physical and radiobiological strengths as well as weaknesses. Using more than one modality in treating cancer is motivated by the idea of exploiting the advantages of different radiation types to overcome the weaknesses that any single modality suffers, and eventually improving the efficacy of cancer therapy. Current efforts on finding an optimal, multi-modality treatment paradigm for a particular cancer type are mostly empirical, and heuristic searches result in a long and costly period of trial-and-error. This award supports research to develop an optimization tool that systematically searches for optimal, multi-modality radiotherapy schemes, which can then be tailored to particular cancer types as needed. The optimal treatment protocols will provide guidance in designing trials of new effective and efficient radiation treatments. If successful, this will lead to longer survival and increase quality of life for cancer patients. The multi-disciplinary project team will include students and trainees in different areas including industrial engineering, applied mathematics, and medical physics, and positively impact education in science and engineering.&lt;br/&gt;&lt;br/&gt;This research utilizes the stochastic control formalism, where the system consists of the tumor and normal tissue subject to the modality-specific uncertainty and tumor-specific radiobiological parameters. The time-dependent beam intensities of multiple radiation types are used as controls, and they determine the spatiotemporal dose distribution during a treatment course. Optimal treatment consists of the maximum biologically-effective-dose or equivalent uniform dose feasible for a given patient's physical and radiobiological condition, which is positively correlated with clinical outcomes. The research team will construct the general optimization framework, apply to specific cancer types using phantom studies, perform numerical simulations to quantify the potential benefits of an optimal solution over the conventional treatment schemes that are currently used in practice, and come up with treatment paradigms that could be tested in future clinical trials.</AbstractNarration>
<MinAmdLetterDate>03/02/2016</MinAmdLetterDate>
<MaxAmdLetterDate>03/02/2016</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>1560476</AwardID>
<Investigator>
<FirstName>Minsun</FirstName>
<LastName>Kim</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Minsun Kim</PI_FULL_NAME>
<EmailAddress>Mk688@uw.edu</EmailAddress>
<PI_PHON>2065434043</PI_PHON>
<NSF_ID>000701362</NSF_ID>
<StartDate>03/02/2016</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>University of Washington</Name>
<CityName>Seattle</CityName>
<ZipCode>981950001</ZipCode>
<PhoneNumber>2065434043</PhoneNumber>
<StreetAddress>4333 Brooklyn Ave NE</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Washington</StateName>
<StateCode>WA</StateCode>
<CONGRESSDISTRICT>07</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>WA07</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>605799469</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>UNIVERSITY OF WASHINGTON</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>042803536</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[University of Washington]]></Name>
<CityName>Seattle</CityName>
<StateCode>WA</StateCode>
<ZipCode>981956043</ZipCode>
<StreetAddress><![CDATA[1959 NE Pacific St.]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Washington</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>07</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>WA07</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>006Y</Code>
<Text>OE Operations Engineering</Text>
</ProgramElement>
<ProgramReference>
<Code>071E</Code>
<Text>MFG ENTERPRISE OPERATIONS</Text>
</ProgramReference>
<ProgramReference>
<Code>072E</Code>
<Text>NETWORKS &amp; QUEUING SYSTEMS</Text>
</ProgramReference>
<ProgramReference>
<Code>073E</Code>
<Text>OPTIMIZATION &amp; DECISION MAKING</Text>
</ProgramReference>
<ProgramReference>
<Code>076E</Code>
<Text>SERVICE ENTERPRISE SYSTEMS</Text>
</ProgramReference>
<ProgramReference>
<Code>077E</Code>
<Text>SIMULATION MODELS</Text>
</ProgramReference>
<ProgramReference>
<Code>078E</Code>
<Text>ENTERPRISE DESIGN &amp; LOGISTICS</Text>
</ProgramReference>
<ProgramReference>
<Code>8023</Code>
<Text>Health Care Enterprise Systems</Text>
</ProgramReference>
<ProgramReference>
<Code>9102</Code>
<Text>WOMEN, MINORITY, DISABLED, NEC</Text>
</ProgramReference>
<Appropriation>
<Code>0116</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2016~299919</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><div class="OutlineElement Ltr SCXW13876740 BCX0"> <p class="Paragraph SCXW13876740 BCX0"><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">Radiotherapy is one of the major treatment modalities for cancer patients. It uses ionizing radiation to eradicate cancer cells while sparing normal tissue in the path of radiation beams.&nbsp; There are different radiation types (</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">e.g., photons, protons, and neutrons</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">) used in current practice&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">since</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;each radiation type works&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">differently&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">in damaging</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;tumor</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;cells</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">.&nbsp; Specifically,&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">how the dose is spatially deposited in the patient?s body (</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SpellingErrorV2 SCXW13876740 BCX0">dosimetric</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;characteristics) and how many cells get killed per unit dose (biological power) depend on&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">the radiation type used in radiotherapy</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">. Due to its unique&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SpellingErrorV2 SCXW13876740 BCX0">dosimetric</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;and biological characteristics,&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">it is unclear which radiation&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">modality</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;or combination of modalities</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;is&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">optimal</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;for each patient.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;Current efforts to select the optimal radiation modality&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">are</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;mostly empirical and largely dependent on individual experiences and clinical intuition. The purpose of this project is to systematically investigate the optimal radiation modality or combination</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;of modalities that lead to the&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">best feasible tradeoff between the tumor damage and normal tissue sparing.</span><span class="EOP SCXW13876740 BCX0">&nbsp;</span></p> </div> <div class="OutlineElement Ltr SCXW13876740 BCX0"> <p class="Paragraph SCXW13876740 BCX0"><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">This project proposes a&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">novel,&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">non-convex</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">, mixed integer</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;optimization framework involving multiple radiation modalities</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">. In this framework,</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">we employ the concept of biologically effective dose (BED), which is a widely accepted measure in the radiation oncology community to estimate the clinical outcome from the radiation dose delivered in multiple fractions, i.e., a larger BED to tumor</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;indicates</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;better clinical outcome.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">In e</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">ach patient-specific plan</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">, the fractionation scheme (how the total dose is broken into multiple fractions to be delivered),&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">a fractional dose size</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">, and radiation dose spatial distributions are simultaneously optimized</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;to maximize BED to the tumor while BEDs to multiple&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">organs-at-risk</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;are constrained to be less than their known tolerance levels.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;In other words, the optimized plan&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">obtained by</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;the novel framework</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;proposed</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;yields the best feasible trade-off between the tumor damage and normal tissue toxicity</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">by&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">exploiting the&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SpellingErrorV2 SCXW13876740 BCX0">dosimetric</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;and biological properties of multiple radiation types.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">An</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;efficient algorithm to solve the proposed</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;large-scale, computationally challenging problem has been developed using&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">a bi-level optimization</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;algorithm, where the upper level optimization algorithm solves the fractionation problem and the lowe</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">r level algorithm solves the dose distribution problem.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">The application of the framework and solution algorithms to a simple 2D phantom case revealed that this method is feasible&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">in clinical practice</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">. Th</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">e compar</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">ative study</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;showed that the&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">BED increase in the optimized plans compared to conventionally designed plans with a single modality</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;indicate a need for further clinical investigation</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">.&nbsp;&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">Finally, t</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">he multi-modality radiotherapy project has been expanded to include non-radiation modalities such as surgery and chemotherapy, which are other major modalities to treat cancer patients</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;to maximize clinical outcome</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;</span><span class="EOP SCXW13876740 BCX0">&nbsp;</span></p> </div> <div class="OutlineElement Ltr  BCX0 SCXW13876740"> <p class="Paragraph SCXW13876740 BCX0"><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">This project</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">has&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">supported&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">2</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">doctoral</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;students in the departme</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">nt of Applied Mathematics</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;and 1&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">doctoral</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;student in the department of&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">Industrial &amp; Systems&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">Engineer</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">ing</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">&nbsp;at the University of Washington in their&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">Ph.D.&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">thesis work.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">The results&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">and findings&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">have been presented in the&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">5 national conferences, 2 local meetings, and 4 research papers.</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US"><span class="NormalTextRun SCXW13876740 BCX0">&nbsp;</span></span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">The</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">y also&nbsp;</span><span class="TextRun SCXW13876740 BCX0" lang="EN-US" xml:lang="EN-US">have been used as preliminary data for another grant awarded in July 2020, which proposes a clinical application of the novel framework developed in this project to patients with cervical cancer.</span><span class="EOP SCXW13876740 BCX0">&nbsp;</span></p> </div> <p>&nbsp;</p><br> <p>            Last Modified: 08/11/2020<br>      Modified by: Minsun&nbsp;Kim</p> </div> <div class="porSideCol"></div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[ Radiotherapy is one of the major treatment modalities for cancer patients. It uses ionizing radiation to eradicate cancer cells while sparing normal tissue in the path of radiation beams.  There are different radiation types (e.g., photons, protons, and neutrons) used in current practice since each radiation type works differently in damaging tumor cells.  Specifically, how the dose is spatially deposited in the patient?s body (dosimetric characteristics) and how many cells get killed per unit dose (biological power) depend on the radiation type used in radiotherapy. Due to its unique dosimetric and biological characteristics, it is unclear which radiation modality or combination of modalities is optimal for each patient. Current efforts to select the optimal radiation modality are mostly empirical and largely dependent on individual experiences and clinical intuition. The purpose of this project is to systematically investigate the optimal radiation modality or combination of modalities that lead to the best feasible tradeoff between the tumor damage and normal tissue sparing.    This project proposes a novel, non-convex, mixed integer optimization framework involving multiple radiation modalities. In this framework, we employ the concept of biologically effective dose (BED), which is a widely accepted measure in the radiation oncology community to estimate the clinical outcome from the radiation dose delivered in multiple fractions, i.e., a larger BED to tumor indicates better clinical outcome. In each patient-specific plan, the fractionation scheme (how the total dose is broken into multiple fractions to be delivered), a fractional dose size, and radiation dose spatial distributions are simultaneously optimized to maximize BED to the tumor while BEDs to multiple organs-at-risk are constrained to be less than their known tolerance levels. In other words, the optimized plan obtained by the novel framework proposed yields the best feasible trade-off between the tumor damage and normal tissue toxicity by exploiting the dosimetric and biological properties of multiple radiation types. An efficient algorithm to solve the proposed large-scale, computationally challenging problem has been developed using a bi-level optimization algorithm, where the upper level optimization algorithm solves the fractionation problem and the lower level algorithm solves the dose distribution problem. The application of the framework and solution algorithms to a simple 2D phantom case revealed that this method is feasible in clinical practice. The comparative study showed that the BED increase in the optimized plans compared to conventionally designed plans with a single modality indicate a need for further clinical investigation.  Finally, the multi-modality radiotherapy project has been expanded to include non-radiation modalities such as surgery and chemotherapy, which are other major modalities to treat cancer patients to maximize clinical outcome.      This project has supported 2 doctoral students in the department of Applied Mathematics and 1 doctoral student in the department of Industrial &amp; Systems Engineering at the University of Washington in their Ph.D. thesis work. The results and findings have been presented in the 5 national conferences, 2 local meetings, and 4 research papers. They also have been used as preliminary data for another grant awarded in July 2020, which proposes a clinical application of the novel framework developed in this project to patients with cervical cancer.            Last Modified: 08/11/2020       Submitted by: Minsun Kim]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
